Johnson & Johnson
JNJ
Market Cap$379.48B
Close$
Earnings Call Q1 2025
April 15, 2025 - AI Summary
Strong Q1 Sales Growth: Johnson & Johnson reported worldwide sales of $21.9 billion for Q1 2025, reflecting a 4.2% operational growth year-over-year. The growth stemmed from a 5.9% increase in the U.S. market and a 2.1% increase internationally, despite experiencing an 810 basis points headwind from the loss of exclusivity for STELARA.
Innovative Medicine Performance: The innovative medicine segment achieved $13.9 billion in sales, marking a 4.2% increase despite STELARA's declining sales, which dropped 32.3% due to biosimilar competition. Notably, DARZALEX sales exceeded $3 billion for the third consecutive quarter with over 20% growth, and key brands in oncology and immunology showed strong double-digit growth.
Dividend Increase and Capital Allocation: Johnson & Johnson announced a 4.8% increase in its quarterly dividend, marking the sixty-third consecutive year of increases. This highlights the company's commitment to returning capital to shareholders even amid challenges with STELARA and tariff implications.
Exclusive for Stockcircle Pro members
Sign up
$208.45
32.1% upside
Current Fair Value
32.1% upsideUndervalued by 32.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $379.48 Billion |
|---|---|
| Enterprise Value | $395.78 Billion |
| Dividend Yield | $4.96 (3.14980631231346%) |
| Earnings per Share | $5.84 |
| Beta | 0.48 |
| Outstanding Shares | 2,406,922,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 26.95 |
|---|---|
| PEG | -176.54 |
| Price to Sales | 4.38 |
| Price to Book Ratio | 5.44 |
| Enterprise Value to Revenue | 4.46 |
| Enterprise Value to EBIT | 19.87 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.57 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Johnson & Johnson
CEO: Alex Gorsky At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today...